AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Microbiome Therapeutics Market 2020: A Benchmark of the Top 10 Companies - ResearchAndMarkets.com

January 4, 2021 GMT

DUBLIN--(BUSINESS WIRE)--Jan 4, 2021--

The “Global Microbiome Therapeutics Market 2020: A Benchmark of the Top 10 Companies” report has been added to ResearchAndMarkets.com’s offering.

Microbiome present in the human body has a major role to play in the overall functioning of the human body. Human microbiota consists of a diverse population of bacterial, viral and eukaryotic communities and is present on skin, nasopharynx, oral cavity, respiratory tract, gastrointestinal tract and female reproductive tract. The naturally occurring microbiota is actively involved in metabolic cycle and the performance of immune system.

ADVERTISEMENT

Today, with deeper understanding of microbiome and its role in human health, we are able to utilize microbiome for developing therapeutics. Designing microbial therapeutics has been challenging, however with the help of genetic engineering tools manipulating these naturally occurring consortia of microbiome has gained momentum in the last five years.

Numerous studies are being conducted to gain deeper understanding of host-microbiome interaction for developing targeted therapeutics. A significant focus of human microbiome research has been studying the bacteria in the gut, which represent the largest community both in terms of abundance and diversity. Microbiome therapeutics companies are increasingly involved in developing therapies for dysbiosis, obesity, inflammatory bowel disease, cancer, even neurological disorders as schizophrenia and autism.

This report profiles companies actively involved in developing microbiome therapeutics.

Key Topics Covered:

1. Strategic Imperative and Growth Environment

  • Strategic Imperative
  • Growth Environment

2. The Radar: Microbiome Therapeutics

3. Companies to Action

  • 4D Pharma PLC
  • ENTEROME
  • Finch Therapeutics
  • Intralytix
  • Locus Biosciences
  • Microbiotica
  • Second Genome
  • Seres Therapeutics
  • Rebiotix - Ferring Pharmaceuticals
  • Vedanta Biosciences

4. Strategic Insights

5. Next Steps: Leveraging The Radar to Empower Key Stakeholders

ADVERTISEMENT

  • Significance of Being on The Radar
  • The Radar Empowers the CEO’s Growth Team
  • The Radar Empowers Investors
  • The Radar Empowers Customers
  • The Radar Empowers the Board of Directors

6. The Radar: Analytics

  • The Radar: Benchmarking Future Growth Potential

For more information about this report visit https://www.researchandmarkets.com/r/eqaupv

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com:https://www.businesswire.com/news/home/20210104005462/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 01/04/2021 09:14 AM/DISC: 01/04/2021 09:14 AM

http://www.businesswire.com/news/home/20210104005462/en